Journal article Open Access


Arjun Sai Sreekar Aeila*, Tirandi.Manohara Sai, A.Rohit Kumar

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="">
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Nanomaterials, Liposomes, Dendrimers, Nanocrystal.</subfield>
  <controlfield tag="005">20200120160539.0</controlfield>
  <controlfield tag="001">3597166</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">545728</subfield>
    <subfield code="z">md5:d16d0775fca058f8cd1a856070cfa547</subfield>
    <subfield code="u"></subfield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-01-03</subfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-iajpr</subfield>
    <subfield code="o"></subfield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">GITAM Institute of Pharmacy, GITAM (Deemed To Be University) Rushikonda, Visakhapatnam, 530045, Andhra Pradesh, India.</subfield>
    <subfield code="a">Arjun Sai Sreekar Aeila*, Tirandi.Manohara Sai, A.Rohit Kumar</subfield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">NANOPARTICLES - THE FUTURE OF DRUG DELIVERY</subfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-iajpr</subfield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u"></subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2"></subfield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;There has been considerable interest in drug delivery research over the past few decades using Particulate delivery systems as carriers of small and large molecules. Particulate structures such as nanoparticles have been used as a physical tool to modify and improve the pharmacokinetic and pharmacodynamic properties of different types of drug molecules. They were used &lt;em&gt;in-vivo&lt;/em&gt; to Protect the drug entity in the systemic circulation, restrict the drug&amp;#39;s access to the selected locations, and deliver the drug to the site of action at a controlled and sustained rate. Different carriers have been used to increase therapeutic benefit in the formulation of nanoparticles for drug delivery research, while minimizing side effects. Here we review different aspects of the formulation of nanoparticles, their characterization, their effects and their applications in the delivery of drug molecules.&lt;/p&gt;</subfield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.3597165</subfield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.3597166</subfield>
    <subfield code="2">doi</subfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
All versions This version
Views 9393
Downloads 7474
Data volume 40.4 MB40.4 MB
Unique views 8989
Unique downloads 7070


Cite as